Tokyo, April 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061304) titled 'Systemic SGLT2 Inhibition for Diabetic Macular Edema: A Scoping Review' on April 18.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Kimitsu Chuo Hospital
Condition:
Condition - Diaetic Maclar Edema
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to evaluate the usefulness of SGLT2 inhibitors in diabetic macular edema through a scoping review.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Articles ...